These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26077779)

  • 1. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
    Perriard G; Mathias A; Enz L; Canales M; Schluep M; Gentner M; Schaeren-Wiemers N; Du Pasquier RA
    J Neuroinflammation; 2015 Jun; 12():119. PubMed ID: 26077779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
    Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
    Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
    Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
    Sénécal V; Deblois G; Beauseigle D; Schneider R; Brandenburg J; Newcombe J; Moore CS; Prat A; Antel J; Arbour N
    Glia; 2016 Apr; 64(4):553-69. PubMed ID: 26649511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.
    Lalive PH; Kreutzfeldt M; Devergne O; Metz I; Bruck W; Merkler D; Pot C
    J Neuroinflammation; 2017 Jul; 14(1):144. PubMed ID: 28738904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis.
    Broux B; Mizee MR; Vanheusden M; van der Pol S; van Horssen J; Van Wijmeersch B; Somers V; de Vries HE; Stinissen P; Hellings N
    J Immunol; 2015 Mar; 194(5):2099-109. PubMed ID: 25617471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
    van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
    Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-26, preferentially produced by T
    Broux B; Zandee S; Gowing E; Charabati M; Lécuyer MA; Tastet O; Hachehouche L; Bourbonnière L; Ouimet JP; Lemaitre F; Larouche S; Cayrol R; Bouthillier A; Moumdjian R; Lahav B; Poirier J; Duquette P; Arbour N; Peelen E; Prat A
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32788322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
    Touil H; Kobert A; Lebeurrier N; Rieger A; Saikali P; Lambert C; Fawaz L; Moore CS; Prat A; Gommerman J; Antel JP; Itoyama Y; Nakashima I; Bar-Or A;
    J Neuroinflammation; 2018 Apr; 15(1):114. PubMed ID: 29673365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 in transverse myelitis and multiple sclerosis.
    Graber JJ; Allie SR; Mullen KM; Jones MV; Wang T; Krishnan C; Kaplin AI; Nath A; Kerr DA; Calabresi PA
    J Neuroimmunol; 2008 May; 196(1-2):124-32. PubMed ID: 18417225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.
    Pomeshchik Y; Kidin I; Korhonen P; Savchenko E; Jaronen M; Lehtonen S; Wojciechowski S; Kanninen K; Koistinaho J; Malm T
    Brain Behav Immun; 2015 Feb; 44():68-81. PubMed ID: 25153903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
    Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
    Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden.
    Huang YM; Liu X; Steffensen K; Sanna A; Arru G; Fois ML; Rosati G; Sotgiu S; Link H
    Mult Scler; 2005 Feb; 11(1):16-23. PubMed ID: 15732262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
    Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
    Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity.
    Yang X; Gao Y; Wang H; Zhao X; Gong X; Wang Q; Zhang X
    J Rheumatol; 2014 Sep; 41(9):1793-800. PubMed ID: 25086075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
    Babaloo Z; Aliparasti MR; Babaiea F; Almasi S; Baradaran B; Farhoudi M
    Immunol Lett; 2015 Apr; 164(2):76-80. PubMed ID: 25625963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.